Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines

Immunopharmacology and Immunotoxicology

Volumn 31, Issue 1, 2009, Pages 108-116

  Orlando, Antonella ^a   Messa, Caterina ^a   Linsalata, Michele ^a   Cavallini, Aldo ^a   Russo, Francesco ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Cell proliferation; Colonic cancer; Gastric cancer; Lactobacillus rhamnosus GG; Polyamines; Probiotic; Tumor cell lines

Indexed keywords

POLYAMINE; PROBIOTIC AGENT;

ARTICLE; BACTERIAL STRAIN; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOPLASM; DRUG ACTIVITY; HUMAN; HUMAN CELL; LACTOBACILLUS RHAMNOSUS; POLYAMINE METABOLISM; PRIORITY JOURNAL; STOMACH CANCER;

BIOGENIC POLYAMINES; BIOSYNTHETIC PATHWAYS; CELL EXTRACTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LACTOBACILLUS RHAMNOSUS; ORNITHINE DECARBOXYLASE; PROBIOTICS; PUTRESCINE; SPERMIDINE; SPERMINE; STOMACH NEOPLASMS;

BACTERIA (MICROORGANISMS); LACTOBACILLUS RHAMNOSUS;

EID: 60749120342     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970802443631     Document Type: Article

References (33)

1. FAO/WHO. Regulatory and Clinical Aspects of Dairy Probiotics. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report, 2001.
2. Salminen, S.; Bouley, C.; Boutron-Ruault, M.C.; Cummings, J.H.; Franck, A.; et al. Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 1998, 80, S147-S171.
3. Conway, P.L.; Gorbach, S.L.; Goldin, B.R. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J. Dairy Sci. 1987, 70, 1-12.
4. Huebner, E.S.; Surawicz, CM. Probiotics in the prevention and treatment of gastrointestinal infections. Gastroenterol. Clin. North Am. 2006, 35(2), 355-365.
5. Lin, D.C. Probiotics as functional foods. Nutr. Clin. Pract. 2003, 18, 497-506.
6. Singh, J.; Rivenson, A.; Tomita, M.; Shimamura, S.; Ishibashi, N.; et al. Bifidobacterium longum, a lactic acid-producing intestinal bacterium, inhibits colon cancer and modulates the intestinal biomarkers of colon carcinogenesis. Carcinogenesis 1997, 18, 833-841.
7. Russo, F.; Orlando, A.; Linsalata, M.; Cavallini, A.; Messa, C. Effects of Lactobacillus Rhamnosus GG on the cell growth and polyamine metabolism in HGC-27 human gastric cancer cells. Nutr. Cancer 2007, 59(1), 106-114.
8. Tabor, C.W.; Tabor, H. Polyamines. Annu. Rev. Biochem. 1984, 53, 749-790.
9. Pegg, A.E.; McCann, P.P. Polyamines metabolism and function. Am. J. Physiol. 1982, 243, C212-C221.
10. Linsalata, M.; Russo, F.; Cavallini, A.; Berloco, P.; Di Leo, A. Polyamines, diamine oxidase and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa. Dis. Colon Rectum 1993, 36, 662-667.
11. Messa, C.; Pricci, M.; Linsalata, M.; Russo, F.; Di Leo, A. Inhibitory effect 17β-estradiol on growth and polyamine metabolism of a human gastric carcinoma cell line (HGC-27). Scand. J. Gastroenterol. 1999, 34, 79-84.
12. Garewal, H.S.; Sloan, D.; Sampliner, R.E.; Fennerty, B. Ornithine decarboxylase assay in human colorectal mucosa: Methodological issues of importance to quality control. Int. J. Cancer 1992, 52, 355-358.
13. Picard, C.; Fioramonti, J.; Francois, A.; Robinson, T.; Neant, F.; Matuchansky, C. Review article: Bifidobacteria as probiotic agents - Physiological effects and clinical benefits. Aliment Pharmacol. Ther. 2005, 22(6), 495-512.
14. Pessi, T.; Sutas, Y.; Saxelin, M.; Kallioinen, H.; Isolauri, E. Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl. Environ. Microbiol. 1999, 65, 4725-4728.
15. Lee, J.W.; Shin, J.G.; Kim, E.H.; Kang, H.E.; Yim, I.B.; et al. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J. Vet. Sci. 2004, 5, 41-48.
16. Charteris, W.P.; Kelly, P.M.; Morelli, L.; Collins, J.K. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J. Appl. Microbiol. 1998, 84(5), 759-768.
17. Kim, J.Y.; Woo, H.J.; Kim, Y.S.; Lee, H.J. Screening for antiproliferative effects of cellular components from lactic acid bacteria against human cancer cell lines. Biotechnol. Lett. 2002, 24, 1431-1436.
18. Santona, S.; Farnworth, E.; Jones, P.J. Probiotics and their potential health claims. Nutr. Rev. 2006, 64, 265-274.
19. Linsalata, M.; Russo, F.; Berloco, P.; Caruso, M.L.; Di Matteo, G.; Cifone, M.G.; De Simone, C.; Ierardi, E.; Di Leo, A. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 2004, 9(2), 165-172.
20. Francavilla, R.; Lionetti, E.; Castellaneta, S.P.; Magistà, A.M.; Maurogiovanni, G.; Bucci, N.; De Canio, A.; Indrio, F.; Cavallo, L.; Ierardi, E.; Miniello, V.L. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: A pilot study. Helicobacter 2008, 13(2), 127-134.
21. Thomas, T.; Thomas, T.J. Polyamines in cell growth and cell death: Molecular mechanisms and therapeutic applications. Cell Mol. Life Sci. 2001, 58, 244-258.
22. Auvinen, M.; Paasinen, A.; Andersson, L.C.; Holtta, E. Ornithine decarboxylase activity is critical for cell transformation. Nature 1992, 360, 355-358.
23. Deloyer, P.; Peulen, O.; Dandrifosse, G. Dietary polyamines and non-neoplastic growth and disease. Eur. J. Gastroenterol. Hepatol. 2001, 3, 1027-1032.
24. Linsalata, M.; Messa, C.; Russo, F.; Cavallini, A.; Di Leo, A. Estrogen receptors and polyamine levels in human gastric carcinoma. Scand. J. Gastroenterol. 1994, 29, 67-70.
25. Russo, F.; Linsalata, M.; Giorgio, I.; Caruso, M.L; Armentano, R.; Di Leo, A. Polyamine levels and ODC activity in intestinal-type and diffuse-type gastric carcinoma. Digest Dis. Sci. 1997, 42, 576-579.
26. Di Leo, A; Linsalata, M.; Cavallini, A.; Messa, C.; Russo, F. Sex steroid hormone receptors, epidermal growth factor receptor and polyamines in human colorectal cancer. Dis. Col. Rectum 1992, 35(4), 305-309.
27. Linsalata, M.; Notarnicola, M.; Caruso, M.G.; Di Leo, A.; Guerra, V.; Russo, F. Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma. Scand. J. Gastroenterol. 2004, 39, 470-477.
28. Choi, S.S.; Kim, Y.; Han, K.S.; You, S.; Oh, S.; Kim, S.H. Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett. Appl. Microbiol. 2006, 42, 452-458.
29. Tejada-Simon, M.V.; Pestka, J.J. Proinflammatory cytokine and nitric oxide induction in murine macrophages by cell wall and cytoplasmic extracts of lactic acid bacteria. J. Food Prot. 1999, 62(12),1435-1444.
30. Cunin, R.; Glansdorff, N.; Pierard, A.; Stalon, V. Biosynthesis and metabolism of arginine in bacteria. Microbiol. Rev. 1986, 50, 314-352.
31. Marquis, R.E.; Bender, G.R.; Murray, D.R.; Wong, A. Arginine deiminase system and bacterial adaptation to acid environments. Appl. Environ. Microbiol. 1987, 53, 198-200.
32. Di Marzio, L.; Russo, F.P.; D'alò, S.; Biordi, L.; Ulisse, S.; Amicosante, G.; De Simone, C. Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities. Nutr. Cancer 2001, 40, 185-196.
33. Famularo, G.; Pieluigi, M.; Coccia, R.; Mastroiacovo, P.; De Simone, C. Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Med. Hypoth. 2001, 56, 421-430.